A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.

R, Ramanathan; MR, Rasmussen; DR, Gerstmann; N, Finer; K, Sekar

doi:10.1055/s-2004-823779

Public

A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.

Shared by NobleBlocks on Apr 1, 2004 • 12:00 AM UTC

Authors:

Ramanathan R

Rasmussen MR

Gerstmann DR

Abstract

We compared the onset of clinical response and safety of two surfactants, poractant alfa (Curosurf, Chiesi Pharmaceuticals, Parma, Italy) and beractant (Survanta, Ross Laboratories, Columbus, OH), for treatment of respiratory distress syndrome (RDS) in preterm infants weighing 750 to 1750 g at birth...

Discussions